StemoniX News and Events
Together with our collaborators at Janssen Pharmaceuticals, we are thrilled to present a new publication in
PLOS ONE featuring
Neurospheroids were screened using the LOPAC Library and showed how microBrain 3D can be used as a screening platform for CNS-based drug discovery!
"Leveraging clinically translatable human iPSC-derived neurospheroids in high-throughput format and AI-based small molecule-protein binding technologies, Atomwise and StemoniX’s first joint venture is focused on generating novel small-molecule assets."
Combined Company Positioned to Offer
Innovative Drug Discovery Solutions
"The new technologies for generating midbrain organoids are a perfect fit for our human-first approach to drug discovery and ability to mass-produce highly reproducible and physiologically relevant iPS cell-based models,” says Ping Yeh, Co-founder and CEO of StemoniX.